30 January, 11.30am - 1pm, Level 7 boardroom, TRF
Presentation title:
Androgen receptor variants: predictive and prognostic
biomarkers, and overcoming treatment resistance in advanced prostate cancer
Synopsis:
The last several years has seen the approval of multiple new
therapies for advanced prostate cancer, particularly targeting the androgen
receptor (AR) axis. Despite improvements in clinical outcomes, resistance to
these agents is inevitable. This project aims to characterise a
predictive biomarker for resistance to AR-axis targeted agents, and determine
alternative treatment approaches to overcome this resistance.
Supervisors:
A/Prof Arun Azad, Dr Sarah To, Prof Eva Segelov
No comments:
Post a Comment